Novel Mechanism of Positive versus Negative Regulation by Thyroid Hormone Receptor β1 (TRβ1) Identified by Genome-wide Profiling of Binding Sites in Mouse Liver
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Triiodothyronine (T3) regulates key metabolic processes in the liver through the thyroid hormone receptor, TRβ1. However, the number of known target genes directly regulated by TRβ1 is limited, and the mechanisms by which positive and especially negative transcriptional regulation occur are not well understood. To characterize the TRβ1 cistrome in vivo, we expressed a biotinylated TRβ1 in hypo- and hyperthyroid mouse livers, used ChIP-seq to identify genomic TRβ1 targets, and correlated these data with gene expression changes. As with other nuclear receptors, the majority of TRβ1 binding sites were not in proximal promoters but in the gene body of known genes. Remarkably, T3 can dictate changes in TRβ1 binding, with strong correlation to T3-induced gene expression changes, suggesting that differential TRβ1 binding regulates transcriptional outcome. Additionally, DR-4 and DR-0 motifs were significantly enriched at binding sites where T3 induced an increase or decrease in TRβ1 binding, respectively, leading to either positive or negative regulation by T3. Taken together, the results of this study provide new insights into the mechanisms of transcriptional regulation by TRβ1 in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FIMO: scanning for occurrences of a given motif
Grant, C. E., Bailey, T. L., & Noble, W. S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr064 · Cited by 4,247
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895 · cited 1×
“The nuclear receptor LXR is known to bind with high affinity to DR-4 elements (38 – 40), whereas PPAR binds to DR-1 elements (41, 42), and FXR binds to IR-1 elements (36).”
BackgroundUhlenhaut, N. H., Barish, G. D., Yu, R. T., Downes, M., Karunasiri, M., Liddle, C., Schwalie, P., Hübner, N., & Evans, R. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.013 · Cited by 265 · cited 1×
“Previous ChIP-seq experiments have helped to confirm that the in vitro binding preference of nuclear receptors such as liver X receptor, glucocorticoid receptor and farnesoid X receptor are preserved in vivo (33, 36, 37).”
STAT3 targets the regulatory regions of gluconeogenic genes in vivo
Ramadoss, P., Unger-Smith, N. E., Lam, F. S., & Hollenberg, A. N. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0264 · Cited by 103
Self-citationThe in vivo role of nuclear receptor corepressors in thyroid hormone action
Astapova, I., & Hollenberg, A. N. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.001 · Cited by 92
Self-citationIdentical gene regulation patterns of T3 and selective thyroid hormone receptor modulator gC-1
Yuan, C., Lin, J. Z. H., Sieglaff, D. H., Ayers, S. D., DeNoto-Reynolds, F., Baxter, J. D., & Webb, P. (2012) · Endocrinology · doi:10.1210/en.2011-1325 · Cited by 70 · cited 1×
“The number of genes regulated by 2-fold is consistent with what has been found in other microarray studies looking at T3 regulation in the liver (17, 20).”
ResultThe thyroid axis is regulated by NCoR1 via its actions in the pituitary
Costa-e-Sousa, R. H., Astapova, I., Ye, F., Wondisford, F. E., & Hollenberg, A. N. (2012) · Endocrinology · doi:10.1210/en.2012-1504 · Cited by 38
Self-citationPaquette, M. A., Dong, H., Gagné, R., Williams, A., Malowany, M., Wade, M. G., & Yauk, C. L. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-634 · Cited by 24
Cited by
Hypothalamus‐Pituitary‐Thyroid Axis
Ortiga‐Carvalho, T. M., Chiamolera, M. I., Pazos‐Moura, C. C., & Wondisford, F. E. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150027 · Cited by 394
Thyroid hormone receptors and resistance to thyroid hormone disorders
Ortiga-Carvalho, T. M., Sidhaye, A. R., & Wondisford, F. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.143 · Cited by 383
New insights into thyroid hormone action
Mendoza, A., & Hollenberg, A. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.012 · Cited by 281
Self-citationChREBP regulates fructose-induced glucose production independently of insulin signaling
Kim, M.-S., Krawczyk, S. A., Doridot, L., Fowler, A. J., Wang, J. X., Trauger, S. A., Noh, H.-L., Kang, H. J., Meissen, J. K., Blatnik, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81993 · Cited by 212
Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature
Flamant, F., Cheng, S.-Y., Hollenberg, A. N., Moeller, L. C., Samarut, J., Wondisford, F. E., Yen, P. M., & Refetoff, S. (2017) · Endocrinology · doi:10.1210/en.2017-00250 · Cited by 165
Self-citationSingh, B. K., Sinha, R. A., Tripathi, M., Mendoza, A., Ohba, K., Sy, J. A. C., Xie, S. Y., Zhou, J., Ho, J. P., Chang, C.-Y., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aam5855 · Cited by 145
Self-citationSingh, B. K., & Yen, P. M. (2017) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-017-0046-z · Cited by 72
Evolution of ligands, receptors and metabolizing enzymes of thyroid signaling
Holzer, G., Roux, N., & Laudet, V. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.021 · Cited by 62
Central vs. Peripheral Action of Thyroid Hormone in Adaptive Thermogenesis: A Burning Topic
Zekri, Y., Flamant, F., & Gauthier, K. (2021) · Cells · doi:10.3390/cells10061327 · Cited by 27
Metadata
- Authors
- Ramadoss, P., Abraham, B. J., Tsai, L., Zhou, Y., Costa-e-Sousa, R. H., Ye, F., Bilban, M., Zhao, K., & Hollenberg, A. N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 289
- Issue
- 3
- Pages
- 1313-1328
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2079698011
- Cited by
- 104
- References
- 8
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.